BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26349548)

  • 1. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.
    Emperador DM; Velasquez DE; Estivariz CF; Lopman B; Jiang B; Parashar U; Anand A; Zaman K
    Clin Infect Dis; 2016 Jan; 62(2):150-6. PubMed ID: 26349548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
    Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
    PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
    Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines.
    Patel M; Steele AD; Parashar UD
    Vaccine; 2012 Apr; 30 Suppl 1():A30-5. PubMed ID: 22520134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
    Cowley D; Sari RM; Handley A; Watts E; Bachtiar NS; At Thobari J; Satria CD; Bogdanovic-Sakran N; Nirwati H; Orsini F; Lee KJ; Kirkwood CD; Soenarto Y; Bines JE
    Vaccine; 2019 Nov; 37(49):7233-7239. PubMed ID: 31607604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants.
    Li RC; Huang T; Li Y; Wang LH; Tao J; Fu B; Si G; Nong Y; Mo Z; Liao X; Luan I; Tang H; Rathi N; Karkada N; Han HH
    Hum Vaccin Immunother; 2016 Mar; 12(3):785-93. PubMed ID: 27149266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial.
    Estívariz CF; Anand A; Gary HE; Rahman M; Islam J; Bari TI; Wassilak SG; Chu SY; Weldon WC; Pallansch MA; Heffelfinger JD; Luby SP; Zaman K
    Lancet Infect Dis; 2015 Aug; 15(8):898-904. PubMed ID: 26093980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
    Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
    Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants.
    Migasena S; Simasathien S; Samakoses R; Pitisuttitham P; Sangaroon P; van Steenis G; Beuvery EC; Bugg H; Bishop R; Davidson BL
    Vaccine; 1995 Feb; 13(2):168-74. PubMed ID: 7625111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.
    Ali A; Kazi AM; Cortese MM; Fleming JA; Moon S; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi AK
    PLoS One; 2015; 10(6):e0127622. PubMed ID: 26035743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
    Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
    Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity.
    Ho MS; Floyd RL; Glass RI; Pallansch MA; Jones B; Hamby B; Woods P; Penaranda ME; Kapikian AZ; Bohan G
    Pediatr Infect Dis J; 1989 Oct; 8(10):692-6. PubMed ID: 2554244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
    Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
    Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial.
    Ali SA; Kazi AM; Cortese MM; Fleming JA; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi A
    J Infect Dis; 2014 Dec; 210(11):1772-9. PubMed ID: 24939906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to improve oral vaccine performance: a systematic review and meta-analysis.
    Church JA; Parker EP; Kirkpatrick BD; Grassly NC; Prendergast AJ
    Lancet Infect Dis; 2019 Feb; 19(2):203-214. PubMed ID: 30712836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
    PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.
    Parker EPK; Praharaj I; Zekavati A; Lazarus RP; Giri S; Operario DJ; Liu J; Houpt E; Iturriza-Gómara M; Kampmann B; John J; Kang G; Grassly NC
    Vaccine; 2018 Jan; 36(2):264-272. PubMed ID: 29217369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.